SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $28.06MP/E –Yield –
Scynexis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Scynexis's pe ratio was 1.1× on Jul 31, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jul 31, 2024 | 1.1× | −0.5 |
| 2023 | Dec 29, 2023 | 1.6× | – |
See a number that looks wrong?